NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study.
Rollinson
S
S
Academic Unit of Haematology and Oncology, Algernon Firth Building, University of Leeds, Leeds, LS2 9JT, United Kingdom.
Roddam
P
P
Willett
E
E
Roman
E
E
Cartwright
R
R
Jack
A
A
Morgan
G J
GJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D001191:Arylamine N-Acetyltransferase / Q000032:analysis*; D016022:Case-Control Studies; D015331:Cohort Studies; D016001:Confidence Intervals; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D005838:Genotype; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000235:genetics*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012016:Reference Values; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012907:Smoking / Q000009:adverse effects
D005819:Genetic Markers; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human